HK1111599A1 - Pharmaceutical compositions for the treatment of cellulite - Google Patents

Pharmaceutical compositions for the treatment of cellulite

Info

Publication number
HK1111599A1
HK1111599A1 HK08102411.9A HK08102411A HK1111599A1 HK 1111599 A1 HK1111599 A1 HK 1111599A1 HK 08102411 A HK08102411 A HK 08102411A HK 1111599 A1 HK1111599 A1 HK 1111599A1
Authority
HK
Hong Kong
Prior art keywords
cellulite
treatment
pharmaceutical compositions
pharmaceutical
compositions
Prior art date
Application number
HK08102411.9A
Other languages
English (en)
Inventor
Massimiliana Landini
Sandro Giuliani
Alessandro Giolitti
Original Assignee
Menarini Ricerche Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from ITMI20042371 external-priority patent/ITMI20042371A1/it
Priority claimed from ITMI20051739 external-priority patent/ITMI20051739A1/it
Application filed by Menarini Ricerche Spa filed Critical Menarini Ricerche Spa
Publication of HK1111599A1 publication Critical patent/HK1111599A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4166—1,3-Diazoles having oxo groups directly attached to the heterocyclic ring, e.g. phenytoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4704—2-Quinolinones, e.g. carbostyril
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4926—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having six membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/06—Preparations for care of the skin for countering cellulitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
    • A61K2800/782—Enzyme inhibitors; Enzyme antagonists

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Birds (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Child & Adolescent Psychology (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Quinoline Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
HK08102411.9A 2004-12-14 2008-03-04 Pharmaceutical compositions for the treatment of cellulite HK1111599A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ITMI20042371 ITMI20042371A1 (it) 2004-12-14 2004-12-14 Composizioni farmaceutiche topiche per il trattamento della cellulite
ITMI20051739 ITMI20051739A1 (it) 2005-09-20 2005-09-20 Composizioni farmaceutiche topiche per il trattamento della cellulite
PCT/EP2005/013041 WO2006063714A1 (en) 2004-12-14 2005-12-06 Pharmaceutical compositions for the treatment of cellulite

Publications (1)

Publication Number Publication Date
HK1111599A1 true HK1111599A1 (en) 2008-08-15

Family

ID=35708888

Family Applications (1)

Application Number Title Priority Date Filing Date
HK08102411.9A HK1111599A1 (en) 2004-12-14 2008-03-04 Pharmaceutical compositions for the treatment of cellulite

Country Status (18)

Country Link
US (1) US20100016324A1 (no)
EP (1) EP1824463A1 (no)
JP (1) JP2008523127A (no)
KR (1) KR20070086101A (no)
AR (1) AR052048A1 (no)
AU (1) AU2005315919B2 (no)
BR (1) BRPI0518554A2 (no)
CA (1) CA2590288A1 (no)
HK (1) HK1111599A1 (no)
IL (1) IL183893A0 (no)
MA (1) MA29145B1 (no)
MX (1) MX2007007015A (no)
NO (1) NO20073575L (no)
NZ (1) NZ555836A (no)
PE (1) PE20060746A1 (no)
RU (1) RU2401098C2 (no)
TN (1) TNSN07203A1 (no)
WO (1) WO2006063714A1 (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100963268B1 (ko) 2006-11-22 2010-06-11 에스케이케미칼주식회사 실로스타졸과 은행잎 추출물을 함유한 약제 조성물
ITMI20070604A1 (it) * 2007-03-26 2008-09-27 Menarini Farma Ind Preparazioni cosmetiche per la riduzione degli inestetismi della cellulite
BRPI1007812B1 (pt) * 2009-03-02 2017-09-26 Doris Maria Hexsel Lipoatrofia cosmetic medicinal
WO2013112040A1 (en) 2012-01-27 2013-08-01 Biotropics Malaysia Berhad Use of certain trioxygenated benzene derivatives in body fat management
CN104161756B (zh) * 2014-06-13 2017-02-01 河北智同医药控股集团有限公司 一种盐酸奥普力农注射液组合物
EA031658B1 (ru) * 2017-06-30 2019-02-28 Акционерное Общество "Верофарм" Антицеллюлитный косметический комплекс
RU2694898C1 (ru) * 2018-08-29 2019-07-18 Талагаева Елена Владимировна Крем для лица и тела

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4147497A (en) 1977-01-04 1979-04-03 Gte Sylvania Incorporated Hand-operable signal device using percussively-ignitable flashlamps
IT1270602B (it) 1994-07-12 1997-05-07 Indena Spa Formulazioni a base di esculoside e loro uso in campo farmaceutico e cosmetico
JP3452986B2 (ja) * 1994-09-13 2003-10-06 花王株式会社 脂肪分解促進剤
JP4182183B2 (ja) 1999-08-24 2008-11-19 ディーエスエム アイピー アセッツ ビー．ブイ． 痩身用皮膚化粧料
FR2802811B1 (fr) * 1999-12-24 2002-02-15 Silab Sa Procede d'extraction d'un principe actif a partir de petales de bigarade, notamment pour le traitement de la cellulite, principe actif obtenu, compositions cosmetiques et traitements adaptes
AU2001238363A1 (en) * 2000-02-15 2001-08-27 Zen Bio, Inc. Compositions for preventing cellulite in mammalian skin
DE10009423A1 (de) 2000-02-28 2001-09-06 Henkel Kgaa Kosmetische und pharmazeutische Zubereitungen
DE10009424A1 (de) 2000-02-28 2001-09-06 Henkel Kgaa Verwendung von Flavonen oder Isoflavonen zur Cellulite-Behandlung
ITMI20011182A1 (it) * 2001-06-05 2002-12-05 Indena Spa Composizioni farmaceutiche e/o cosmetiche per il trattamento di adiposita' localizzate e della cellulite
US7754230B2 (en) * 2004-05-19 2010-07-13 The Regents Of The University Of California Methods and related compositions for reduction of fat

Also Published As

Publication number Publication date
IL183893A0 (en) 2007-10-31
EP1824463A1 (en) 2007-08-29
CA2590288A1 (en) 2006-06-22
NO20073575L (no) 2007-09-13
MA29145B1 (fr) 2008-01-02
NZ555836A (en) 2009-09-25
US20100016324A1 (en) 2010-01-21
PE20060746A1 (es) 2006-09-06
WO2006063714A1 (en) 2006-06-22
JP2008523127A (ja) 2008-07-03
AU2005315919B2 (en) 2011-06-09
BRPI0518554A2 (pt) 2008-11-25
AU2005315919A1 (en) 2006-06-22
AR052048A1 (es) 2007-02-28
KR20070086101A (ko) 2007-08-27
MX2007007015A (es) 2007-07-04
RU2007120465A (ru) 2009-01-27
RU2401098C2 (ru) 2010-10-10
TNSN07203A1 (en) 2008-11-21

Similar Documents

Publication Publication Date Title
GB0522311D0 (en) Pharmaceutical compositions for the treatment of pain
IL185462A0 (en) New pharmaceutical compositions useful in the treatment of pain
TWI369987B (en) New pharmaceutical compositions for the treatment of hyper-proliferative disorders
IL178730A0 (en) New pharmaceutical compositions for the treatment of sexual disorders ii
EP1727530A4 (en) TOPICAL FORMULATIONS FOR THE TREATMENT OF DERMATOLOGICAL CONDITIONS
IL181896A0 (en) Methods and compositions for the treatment of hyperlipidemia
EP2107909A4 (en) PHARMACEUTICAL COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF HEPATIC DISORDERS
ZA200703601B (en) Medicaments for the treatment or prevention of fibriotic diseases
IL183537A0 (en) Compositions comprising immunomodulatory compounds and the use thereof for the treatment of immunodeficiency disorders
ZA200703087B (en) Methods and compositions for the treatment of hyperlipidemia
IL192415A0 (en) Pharmaceutical composition for the treatment of nail diseases
IL187405A0 (en) Methods and compositions for the treatment of pain
HK1111599A1 (en) Pharmaceutical compositions for the treatment of cellulite
IL179337A0 (en) Pharmaceutical compositions for the treatment of pruritus
EP1740541A4 (en) THERAPEUTIC FORMULATIONS OF DESOXYEPOTHILONES
IL186022A0 (en) Dermatological compositions and salts for the treatment of dermatological diseases
ZA200707955B (en) Methods and pharmaceutical compositions for the treatment of neurological damage
EP1904088A4 (en) COMPOSITIONS AND METHODS FOR TREATING CANCER
PT2474528E (pt) Compostos antineoplásicos e composições farmacêuticas dos mesmos
HU0500145D0 (en) Composition for the treatment of oral diseases
EP1797430A4 (en) METHOD AND COMPOSITIONS FOR DIAGNOSIS AND TREATMENT OF CANCER
HUP0500685A2 (en) Pharmaceutical composition for the treatment of psychosis
ZA200710476B (en) Methods and compositions for the treatment of pain
ZA200603126B (en) Pharmaceutical compositions for therapeutic use
GB0313630D0 (en) Compositions for the enhanced treatment of depression

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20141206